Prelamin A protein causes accelerated ageing disorders and also prevents the spread of cancer cells

August 12, 2013, Wellcome Trust Sanger Institute
Absence of progeroid phenotype in ZMPSTE24 mosaic mice. (a) Breeding scheme. ZMPSTE24/HprtZ24 male mice were bred with ZMPSTE24þ/Hprtþ/þ female mice to yield female offspring that were either ZMPSTE24/HprtZ24/þ (mosaic) or ZMPSTE24þ/HprtZ24/þ (HTcontrol). DOI: 10.1038/ncomms3268

Researchers have found that a protein responsible for accelerated aging disorders can dramatically slow down the spread of cancers.

The team revealed that prelamin A, responsible for accelerated ageing in a condition called progeria, can prevent the progression of malignant or cancerous tumours. They achieved this by using mosaic mouse models, genetically modified bearing the prelamin A in half of their cells.

Ageing and cancer are intimately related processes, but their links are complex. The risk of developing tumours increases with age, but some of the mechanisms favouring ageing can also slow down the appearance and development of cancer. The results from this study represent an advance in the understanding of the underlying that link age and , as well as possible new in the future.

"Mice with prelamin A in all their cells more quickly and do not live longer than 4-5 months, which extremely hampers the study of cancer, as there is no time for the disease to fully develop," indicates Jorge de la Rosa, first author from Instituto de Medicina Oncológica y Molecular de Asturias.

Researchers previously developed mice that have an underactive ZMPSTE24 gene that mimic the ageing disorder progeria to test for possible treatments. This causes the protein prelamin A to accumulate and in turn results in progeria. To better study the association of ageing and cancer development, the team developed a mosaic model where ZMPSTE24 was underactive in half of the cells and working normally in the other half of the cells.

"Mosaic mice, however, live as long as normal mice, up to two to three years, and they keep 50% of cells with prelamin A in all their tissues throughout , which has permitted us to study the effect of this protein on cancer," comments Juan Cadiñanos, lead author from the Instituto de Medicina Oncológica y Molecular de Asturias.

The team found that the mosaic mice were completely healthy, without any of the physical deformities shown by mice with prelamin A-induced progeria: reduced size and weight, loss of fat, infertility and premature death. This suggests that it might not be necessary to correct the defects in all the cells of patients with progeria, but only some. These results provide hope for a successful treatment of patients with in the future.

The team studied the development of tumours such as skin, lung and mouth cancers in the mosaic mice. Although the mosaic mice developed the same number of tumours as normal mice, they had fewer cancerous or malignant tumours - tumours cells that can break through the biological barriers that confine them and spread to other tissues in the body. They could also check the anti-invasive effect of prelamin A on human oral, lung and breast cancer cells.

Accumulation of prelamin A in appears not to stop or reduce the initiation and development of tumour growth, but greatly reduces the capacity of the tumour to become cancerous and spread to other parts of the body. The role prelamin A has to prevent the invasion of cancer suggests that ZMPSTE24 could be an attractive new target for cancer therapy.

"Our results are extremely exciting and offer great potential for the development of new therapies against both cancer and accelerated ageing disorders," says Dr Allan Bradley, author from the Wellcome Trust Sanger Institute. "These mouse models are invaluable for understanding the origins of disease and also to inspire new treatments against these debilitating conditions."

Explore further: Promising treatment for progeria within reach

More information: de la Rosa, J. et al. Prelamin A causes progeria through cell-extrinsic mechanisms and prevents cancer invasion? Nature Communications 2013. DOI: 10.1038/ncomms3268

Related Stories

Promising treatment for progeria within reach

May 16, 2013
Pharmaceuticals that inhibit a specific enzyme may be useful in treating progeria, or accelerated aging in children. A new study performed at the Sahlgrenska Academy indicates that the development of progeria in mice was ...

Alternative target for breast cancer drugs

July 19, 2013
Scientists have identified higher levels of a receptor protein found on the surface of human breast tumour cells that may serve as a new drug target for the treatment of breast cancer. The results, which are published today ...

Research in mice identifies new treatment options for bowel cancer

July 8, 2013
Researchers have discovered the genetic processes that cause specific types of bowel cancer. Using this knowledge, they identified cancer drugs that target these genes. Their findings offer the opportunity to develop personalised ...

Blocking key enzyme in cancer cells could lead to new therapy

August 1, 2013
Researchers from the University of Illinois at Chicago College of Medicine have identified a characteristic unique to cancer cells in an animal model of cancer—and they believe it could be exploited as a target to develop ...

Cancer stem cells isolated from kidney tumors

December 13, 2012
Scientists have isolated cancer stem cells that lead to the growth of Wilms' tumours, a type of cancer typically found in the kidneys of young children. The researchers have used these cancer stem cells to test a new therapeutic ...

Recommended for you

Exercise-induced hormone irisin triggers bone remodeling in mice

December 13, 2018
Exercise has been touted to build bone mass, but exactly how it actually accomplishes this is a matter of debate. Now, researchers show that an exercise-induced hormone activates cells that are critical for bone remodeling ...

Law professor suggests a way to validate and integrate deep learning medical systems

December 13, 2018
University of Michigan professor W. Nicholson Price, who also has affiliations with Harvard Law School and the University of Copenhagen Faculty of Law, suggests in a Focus piece published in Science Translational Medicine, ...

Pain: Perception and motor impulses arise in brain independently of one another

December 13, 2018
Pain is a negative sensation that we want to get rid of as soon as possible. In order to protect our bodies, we react by withdrawing the hand from heat, for example. This action is usually understood as the consequence of ...

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

Drug targets for Ebola, Dengue, and Zika viruses found in lab study

December 13, 2018
No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes ...

Researchers give new insight to muscular dystrophy patients

December 13, 2018
New research by University of Minnesota scientists has revealed the three-dimensional structure of the DUX4 protein, which is responsible for the disease, facioscapulohumeral muscular dystrophy (FSHD). Unlike the majority ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.